Salim Yazji - Jan 3, 2024 Form 4 Insider Report for Oncternal Therapeutics, Inc. (ONCT)

Role
Chief Medical Officer
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Stock symbol
ONCT
Transactions as of
Jan 3, 2024
Transactions value $
-$9,794
Form type
4
Date filed
1/5/2024, 04:00 PM
Previous filing
Oct 4, 2023
Next filing
Feb 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONCT Common Stock Tax liability -$9.79K -19.7K -13.31% $0.50 129K Jan 3, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.